G6PD and infection: Of the 13 patients with P. vivax, P. ovale, mixed infection, or undetermined species infection, nine (69%) received terminal prophylaxis with primaquine, after exclusion of deficiency of glucose-6-phosphate dehydrogenase (G6PD).